Found 9 dm-renal-electrolyte-and-hypertension trials
A listing of dm-renal-electrolyte-and-hypertension medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The Nephrotic Syndrome Study Network (NEPTUNE) is a multi-disciplinary, multi-center longitudinal observational study. The main purpose of this study is to find markers for progression of Nephrotic Syndrome. We are particularly interested in the diseases called Focal and Segmental Glomerulosclerosis (FSGS), Minimal Change Disease (MCD), and Membranous Nephropathy (MN), which …
The research study is being conducted to see how well the investigational drug, Nefecon, works for the treatment of your kidney disease and more specific for patients with "primary immunoglobulin A nephropathy," called IgAN.
This study will use a new investigational study drug called OMS721 in people with Immunoglobulin A (IgA) Nephropathy. This kidney disease produces abnormal amounts of a protein called IgA in the kidney that damage the filtering units or glomeruli. Glomeruli are tiny filtering units in the kidney that remove excess …
This is a Phase 3b, multicenter, open-label extension (OLE) study to evaluate the efficacy and safety of Nefecon treatment in patients with IgAN who have completed the Phase 3 Study Nef 301 and continue to be treated with a stable dose of RAS inhibitor therapy (ACEIs and/or ARBs). Patients who …
There are several different types of glomerular diseases, such as minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), and immunoglobulin A nephropathy (IgAN). Over time, these diseases may cause kidney damage. Because these kidney diseases are rare, it is difficult for individual researchers to gather a large …
Autosomal dominant polycystic kidney disease (ADPKD) is a multi-organ disorder that results in clusters of fluid-filled cysts in the kidneys and other organs leading to progressive enlargement and loss of organ function. ADPKD is a genetic disorder caused by mutations in the PKD1 and PKD2 genes, which encode the proteins …
The research study is being conducted to learn how well a test called Prospera can detect rejection in a transplanted kidney after a biopsy. If results of the biopsy do not indicate rejection, the study team will follow your condition by reviewing your clinical visits for one year, at which …
In this study, the Investigators at the University of Pennsylvania will assess organ-specific biomarker profiles (proteins and metabolites), in order to better understand biologic processes, the interplay between the heart and extracardiac organs, and their role in human disease, with an emphasis on cardiovascular disease. The study will specifically focus …
The objective of TRIO CAP is to continue to collect safety and effectiveness data on the Paradise System in hypertensive subjects inadequately controlled with three antihypertensive medications, similar to those randomized in the RADIANCE-HTN Study TRIO Cohort, until the Paradise Ultrasound Renal Denervation System becomes commercially available. Reduction in average …
